Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Monday, September 29

5:20 PM - 5:30 PM PT

265 - Long-Term Follow-Up Results after Stereotactic Body Radiotherapy for Primary Renal Cell Carcinoma: A Prospective Multicenter Phase 2 Trial
Speaker: Onishi, Hiroshi, MD, PhD - University of Yamanashi, Chuo-shi 409-3898, Yamanashi
5:20 PM - 5:30 PM PT

270 - Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial
Speaker: Dang, Alexa, MD - BC Cancer Agency Vancouver, Vancouver, BC
5:20 PM - 5:30 PM PT

275 - Clinical Outcomes of Biology-Guided Radiation Therapy for Osseous Metastases
Speaker: Wang, Pule, MD - City of Hope Cancer Center, Duarte, CA
5:25 PM - 5:30 PM PT

1028 - Dosimetric Predictors of Sexual Toxicity in Cervical Cancer Patients Treated with Definitive Chemoradiation and MRI-Guided Brachytherapy
Speaker: Gulstene, Stephanie, MD - London Regional Health Sciences, London, ON
5:25 PM - 5:30 PM PT

1034 - Total Radiotherapy Treatment Time in Head and Neck Cancer Patients Treated with IGRT in a Latin American Middle-Income Country
Speaker: Copeland, Paul, BA - University of Chicago Pritzker School of Medicine, Chicago, IL
5:30 PM - 5:35 PM PT

1029 - Comparative Efficacy Analysis between Adjuvant Pelvic External Beam Radiation Treatment and Vaginal Cuff Brachytherapy for Women with 2009 FIGO Stage II Uterine Carcinoma with Pathologic Negative Lymph Node Evaluation
Speaker: Bhatnagar, Aseem, MD - Henry Ford Hospital, Detroit, MI
5:30 PM - 5:35 PM PT

1035 - Global Efforts to Reduce Pediatric Cancer Care Disparities: A Decade Change
Speaker: Mailhot Vega, Raymond, MD, MPH - University of Florida, Jacksonville, FL
5:30 PM - 5:40 PM PT

262 - Safety and Potential Radiosensitizing Effect of Olaparib in Combination with Breast Radiotherapy for TNBC Patients with Residual Disease: Long-Term Results from a Phase I Trial
Speaker: Loap, Pierre, MD - Institut Curie, Paris, Ile de France
5:30 PM - 5:40 PM PT

267 - Neoadjuvant Pembrolizumab and Stereotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma (NAPSTER): A Phase II Randomized Clinical Trial
Speaker: Ali, Muhammad, MBBS, FCPS, FRANZCR - Peter MacCallum Cancer Centre, Melbourne 8006, VIC
5:30 PM - 5:40 PM PT

271 - Outcomes of SABR or Surgery for Early-Stage Lung Cancer in Patients with Interstitial Lung Disease (ILD)
Speaker: Tomassen, Mathijs, MD - Amsterdam UMC location VUMC, Amsterdam, Noord-Holl
5:30 PM - 5:40 PM PT

276 - Design and Implementation of Combined Spatially Fractionated Radiotherapy and Image-Guided On-Treatment Biopsy for Resectable Soft Tissue Sarcoma Patients Enrolled in Prospective Clinical Trial LCCC2250
Speaker: Rankine, Leith, PhD - University of North Carolina, Chapel Hill, NC
5:35 PM - 5:55 PM PT

Question and Answers
Speaker: Romano, Kara, MD - University of Virginia, Charlottesville, Virginia